CoreWeave ( CRWV ) presented its first quarter fiscal results last week, showing what appears to be strong operating momentum in the competitive cloud AI space. However, the market’s reaction was worse: shares fell nearly 19% on Friday, wiping billions of market value. Shares are down more than 57% from their 52-week high.
Investors—already in awe of the company’s trajectory amid intense competition and economic headwinds—found little reassurance in the report. The main culprits were CoreWeave’s failing direction that fell short of expectations and a ballooning debt load that overshadowed any positives.
For a stock that has faced pre-existing concerns about profitability and liquidity, this earnings has only served to increase the worries rather than allay them.
barchart.com
The results painted a mixed picture with undeniable upside. Revenue growth remains impressive, reflecting increased demand for AI infrastructure, and the company’s contracted backlog has grown significantly to $66.8 billion, with an average contract term of five years. Yet CoreWeave missed analyst EPS estimates of a loss of $0.61 and a broader loss of $0.84.
This backlog—fueled by commitments from hyperscalers, AI startups, and enterprises—shows strong visibility for the future and positions CoreWeave as a key player in the AI boom. Adjusted EBITDA margin also held firm in the quarter, underscoring its efficiency in core operations.
However, these positives were quickly overshadowed by red flags fueling the selloff.
Debt levels tripled year-on-year (YoY) as the company ramps up investments in data centers and GPU acquisitions to meet demand.
The number of shares more than doubled by the dilution fund, destroys the value of each share.
Losses have widened, as the net shortfall is due to rising sales, marketing, and infrastructure costs—costs that are important to scale but painful in the short term.
The next quarter’s projected revenue guidance is below consensus estimates, suggesting a possible slowdown that contradicts the story of unmarked growth.
This earnings release has sparked a heated debate among market watchers about the sustainability of CoreWeave’s model. On the other hand, well-known short seller Jim Chanos has questioned the company’s accounting practices, particularly the use of a 10-year depreciation schedule for GPUs, which is longer than the industry standard of six years. He says this increases reported profits by offsetting costs, and when factoring in full economic costs, the company remains deeply unprofitable.
He also expressed concern about CoreWeave’s growing debt burden, and high interest payments that could be huge operating gains, leading to continued negative pre-tax income in the coming quarters. His skepticism extends to the quality of the backlog—whether these long-term contracts are as strong as they’ve been portrayed or are at risk of being canceled amid shifting AI priorities.
Rittenhouse Research has argued that such criticism ignores the potential for exponential growth in AI, where early investment paves the way for big returns. It emphasized that margin compression is temporary, with management predicting a repeat, and that the scale of the backlog validates the strategy despite imminent pain.
Wall Street, on the other hand, doesn’t seem too alarmed by the turmoil. Deutsche Bank upgraded CRWV from “Hold” to “Buy,” raising its price target from $100 to $140, pinning hopes on the company’s AI leadership. Similarly, DA Davidson raised its price target from $110 to $125, highlighting strong demand.
Overall, among the 30 analysts covering the stock, the consensus rating is “Average Buy,” with an average price target of $122.96, implying a potential upside of 54.5% from current levels.
barchart.com
The market’s sharp skepticism is in stark contrast to analysts’ expectations, as Q1 results failed to ease long-standing concerns over rising debt, shrinking, and profit constraints in the capital-intensive industry.
Until CoreWeave shows that this quarter marks a trough—as management insists—and delivers on its promises of margin recovery and full-year growth acceleration, CRWV stock appears to be the best position to hold for cautious investors.
As of the date of publication, Rich Duprey did not have (directly or indirectly) positions in any of the securities mentioned in this article. All information and data in this article is for informational purposes only. This article was originally published on Barchart.com
